LivaNova PLC (LIVN)

Currency in USD
91.32
+1.12(+1.24%)
Closed·
91.320.00(0.00%)
·
LIVN is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
88.6392.31
52 wk Range
52.3799.38
Key Statistics
Prev. Close
90.2
Open
89.88
Day's Range
88.63-92.31
52 wk Range
52.37-99.38
Volume
742.28K
Average Volume (3m)
666.65K
1-Year Change
64.9566%
Book Value / Share
24.90
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LIVN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
105.09
Upside
+15.08%
Members' Sentiments
Bearish
Bullish
ProTips
9 analysts have revised their earnings downwards for the upcoming period

LivaNova PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

9 Buy
1 Hold
1 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 105.09
(+15.08% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Barclays
Buy120.00+31.41%105.00Maintain09-11-2026
Baird
Buy111.00+21.55%95.00Maintain05-11-2026
Mizuho
Buy115.00+25.93%95.00Maintain04-11-2026
Jefferies
Buy120.00+31.41%100.00Maintain04-11-2026
Barclays
Buy105.00+14.98%-New Coverage06-10-2026

LivaNova PLC SWOT Analysis


Cardio Innovation
LivaNova's Essenz heart-lung machine leads a "generational product cycle," poised to drive significant growth through 2027 in the cardiopulmonary market
Financial Pulse
Analysts project 6-7% organic growth, with potential to exceed in 2025. Price targets range from $56 to $80, suggesting upside potential
Pipeline Prospects
Explore LivaNova's diversification strategy with promising developments in sleep apnea and depression treatments, potentially opening new revenue streams
Market Challenges
Delve into LivaNova's navigation of mature franchises, regulatory hurdles, and legal uncertainties, balancing innovation against competitive pressures
Read full SWOT analysis

Earnings

Latest Release
04-11-2026
EPS / Forecast
1.23 / 1.06
Revenue / Forecast
393.1M / 381.1M
EPS Revisions
Last 90 days

LIVN Income Statement

Compare LIVN to Peers and Sector

Metrics to compare
LIVN
Peers
Sector
Relationship
P/E Ratio
25.7x14.8x−0.2x
PEG Ratio
0.140.420.00
Price/Book
3.7x3.6x2.6x
Price / LTM Sales
3.3x1.9x2.8x
Upside (Analyst Target)
15.1%60.8%65.0%
Fair Value Upside
Unlock24.3%9.6%Unlock

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers. The company sells its medical devices through direct sales representatives, agents, and independent distributors in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
37.38M67.86%3.41B
Other Institutional Investors
29.55M32.14%2.70B
Public Companies & Retail Investors
0.000.00%0.00
Total
66.93M100.00%6.11B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.13.73%75,65,3426,90,867
PRIMECAP Management Company7.57%41,68,3773,80,656

FAQ

What Is the LivaNova PLC (LIVN) Share Price Today?

The LivaNova PLC share price today is 91.32.

What is the current LivaNova PLC (LIVN) share price and day range?

As of 14-11-2026, the LivaNova PLC share price is 91.32, with a previous close of 90.20. The share price has ranged from 88.63 to 92.31 today, while the 52-week range spans from 52.37 to 99.38.

What Is the LivaNova PLC Market Cap?

As of today, LivaNova PLC market cap is 4.97B.

What Is the LivaNova PLC (LIVN) Share Price Target?

The average 12-month share price target for LivaNova PLC is 105.09, with a high estimate of 120 and a low estimate of 75. 9 analysts recommend buying, while 1 suggest selling, with an overall rating of Buy and +15.08% Upside potential.

What Is LivaNova PLC's Earnings Per Share (TTM)?

The LivaNova PLC EPS (TTM) is 3.58.

When Is the Next LivaNova PLC Earnings Date?

LivaNova PLC will release its next earnings report on 24-02-2027.

From a Technical Analysis Perspective, Is LIVN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

What Stock Exchange Does LivaNova PLC Trade On?

LivaNova PLC is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for LivaNova PLC?

The stock symbol for LivaNova PLC is "LIVN."

How Many Times Has LivaNova PLC Stock Split?

LivaNova PLC has split 0 times.

How Many Employees Does LivaNova PLC Have?

LivaNova PLC has 3300 employees.

What Is the LIVN Premarket Price?

LIVN's last pre-market stock price is 91.68. The pre-market share volume is 90.00, and the stock has changed by 1.48, or 1.64%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.